Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System

Zhichao Min1, Yuanyuan Mi2, Zhiwei Lv3

  • 1Department of Urology, The First People's Hospital of Hangzhou Lin'an District, Hangzhou 310000, China.

Disease Markers
|January 27, 2022
PubMed
Abstract

Insights

Genetic variations in the mammalian target of rapamycin (mTOR) pathway, specifically the rs2295080 T/G polymorphism, are linked to increased cancer risk, particularly for urinary system cancers. This finding aids in understanding cancer susceptibility and progression.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Genetic polymorphisms in the mammalian target of rapamycin (mTOR) signaling pathway can affect cancer susceptibility.
  • Previous studies on mTOR gene variants rs2295080 T/G and rs1883965 G/A and cancer risk have yielded inconsistent results.

Purpose of the Study:

  • To comprehensively investigate the association between mTOR gene polymorphisms and cancer susceptibility.
  • To evaluate the impact of specific mTOR variants (rs2295080 T/G and rs1883965 G/A) on cancer risk.

Main Methods:

  • A pooled analysis of 22 case-control studies (14,747 cancer patients, 16,399 controls).
  • Statistical assessment using odds ratios (ORs) and 95% confidence intervals (CIs).
  • In silico tools, immunohistochemical staining (IHS), and Gene Set Enrichment Analysis (GSEA) to evaluate mTOR expression and pathway enrichment.

Main Results:

  • The rs2295080 T/G polymorphism was significantly associated with overall cancer risk (e.g., G-allele vs. T-allele: OR=0.89, P=0.023), particularly for urinary system, breast, and blood cancers.
  • The rs1883965 G/A variation showed an association with digestive cancer susceptibility.
  • IHS revealed mTOR upregulation in prostate and bladder cancers, with GSEA indicating enrichment of insulin and mTOR signaling pathways in high mTOR expression groups.

Conclusions:

  • The mTOR rs2295080 T/G polymorphism may contribute to urinary cancer susceptibility.
  • mTOR expression levels are positively correlated with tumor malignancy in prostate cancer, suggesting its role in disease progression.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.6K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K